Similarly, no significant differences were found between MM patients in CR, PR and stable or progressive disease when assessing relative or absolute CD4+FOXP3+ T cell counts in PB before HDC and at the day of engraftment following auto-HSCT (Table 6). The gene discussed is CD4; the disease is Miyoshi myopathy.